Statement of Retraction: Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer (Artificial Cells, Nanomedicine, and Biotechnology, (2016), 44, 1, (290-297), 10.3109/21691401.2014.944646);Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer

Artificial Cells, Nanomedicine and Biotechnology

Volumn 44, Issue 1, 2016, Pages 290-297

  Ebrahimi, Eommolbanin ^b   Akbarzadeh, Abolfazl ^a,b   Abbasi, Elham ^b   Khandaghi, Amir Ahmad ^c   Abasalizadeh, Farhad ^b   Davaran, Soodabeh ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biomedical applications; Doxorubicin; PLGA; Polymeric nanoparticles

Indexed keywords

ALKALINITY; CONTROLLED DRUG DELIVERY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; FUNCTIONAL POLYMERS; IRON OXIDES; MAGNETITE; MEDICAL APPLICATIONS; PRECIPITATION (CHEMICAL); RING OPENING POLYMERIZATION; SCANNING ELECTRON MICROSCOPY; TARGETED DRUG DELIVERY; X RAY POWDER DIFFRACTION;

ANTI-CANCER AGENTS; BIOMEDICAL APPLICATIONS; CHEMICAL PRECIPITATION; DOXORUBICIN; DRUG DELIVERY SYSTEM; PLGA; POLYMERIC NANOPARTICLES; VIBRATING SAMPLE MAGNETOMETRY;

MAGNETIC NANOPARTICLES;

DOXORUBICIN; IRON SALT; MACROGOL 10000; MAGNETITE NANOPARTICLE; POLYGLACTIN; ANTINEOPLASTIC ANTIBIOTIC; LACTIC ACID; MACROGOL DERIVATIVE; MAGNETITE; POLYETHYLENE GLYCOL 1000; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; IN VITRO STUDY; INFRARED SPECTROSCOPY; MAGNETOMETRY; NANOENCAPSULATION; PRECIPITATION; RING OPENING METATHESIS POLYMERIZATION; SCANNING ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION; CHEMISTRY; DRUG FORMULATION; POLYMERIZATION; PROCEDURES; ULTRASTRUCTURE;

ANTIBIOTICS, ANTINEOPLASTIC; CHEMICAL PRECIPITATION; DOXORUBICIN; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; FERROSOFERRIC OXIDE; LACTIC ACID; MAGNETITE NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERIZATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84971667791     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.1080/21691401.2022.2060559     Document Type: Erratum

References (65)

1. Abbasi E, Akbarzadeh A, Kouhi M, Milani M. 2014a. Graphene: synthesis, bio-applications, and properties. Artif Cells Nanomed Biotechnol. 43: 1-7.
2. Abbasi E, Fekri Aval S, Akbarzadeh A, Milani M, Tayefi Nasrabadi H, Joo SW, et al. 2014b. Dendrimers: synthesis, applications and properties. Nanoscale Res Lett. 9: 247.
3. Abbasi E, Milani M, Fekri Aval S, Kouhi M, Akbarzadeh A, Tayefi Nasrabadi H, et al. 2014c. Silver nanoparticles: Synthesis, properties, bio-applications and limitations. Crit Rev Microbiol. 1-8.
4. Ahmadi A, Shirazi H, Pourbagher N, Akbarzadeh A, Omidfar K. An electrochemical immunosensor for digoxin using core-shell gold coated magnetic nanoparticles as labels. Mol Biol Rep. 2014 Jan 7. Epub Ahead of Print.
5. 4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine. 7: 511-526.
6. Akbarzadeh A, Mohamad S, Davaran S. 2012b. Magnetic nanoparticles: preparation, physical properties and applications in biomedicine. Nanoscale Res Lett. 7: 144-157.
7. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. 2013. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8: 102.
8. Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, Davaran S. 2012c. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. J Nanobiotechnology. 10: 46.
9. Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Goganian AM, Khiabani HK, Davaran S. 2012d. Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Int J Nanotechnol Sci Environ. 5: 13-25.
10. Alizadeh E, Akbarzadeh A, Eslaminejad MB, Barzegar A, Hashemzadeh S, Nejati-Koshki K, Zarghami N. 2014a. Up-regulation of liver enriched transcription factors (HNF4a and HNF6) and liver specific microRNA (miR-122) by inhibition of Let-7b in mesenchymal stem cells. Chem Biol Drug Design. (in press).
11. Alizadeh E, Zarghami N, Eslaminejad MB, Akbarzadeh A, Barzegar A, Mohammadi SA. 2014b. The effect of dimethyl sulfoxide (DMSO) on hepatic differentiation of mesenchymal stem cells. Artif Cells Nanomed Biotechnol. 43: 1-8.
12. Alizadeh E, Zarghami N, Eslaminejad MRB, Akbarzadeh A, Jahangir S, Barzegar A, et al. 2014c. The effect of dimethyl sulfoxide on hepatogenic differentiation of mesenchymal stem cells. Int J Pediatrics. 1(2): 57-58.
13. Allemann E, Gurny R, Doelker E. 1993. Drug-loaded nanoparticles-prepa ration methods and drug targeting issues. Eur J Pharm Biopharm. 39: 173.
14. Bagheri S, Hassani SM, Naderi Gh. 2012. Theoretical study on physicochemical and geometrical properties of Doxorubicin and Daunorubicin conjugated to PEO-b-PCL nanoparticles. Eur J Exp Biol. 2: 641-645.
15. Cancer Research UK. 2013. Registered charity in England and Wales (1089464), Scotland (SC041666) and the Isle of Man (1103)
16. Chavanpatil M, Khdair A, Panyam J. 2007. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules. Pharm Res. 24: 803-810.
17. Chouhan R, Bajpai A. 2009. Real time in-vitro studies of doxorubicin release from PHEMA nanoparticles. J Nanobiotech. 7: 5-16.
18. Davaran S, Akbarzadeh A, Nejati-Koshki K, Alimohammadi S, Ghamari MF, Soghrati MM, et al. 2013. In vitro studies of NIPAAM-MAA-VP copolymer-coated magnetic nanoparticles for controlled anticancer drug release. J Encapsulation Adsorpt Sci. 3: 108-115.
19. Davaran S, Alimirzalu S, Nejati-Koshki K, Nasrabadi HT, Akbarzadeh A, Khandaghi AA, et al. 2014a. Synthesis and study of physicochemical characteristics of Fe3O4 magnetic nanocomposites based on poly(Nisopropylacrylamide)for anti-cancer drugs delivery. Asian Pac J Cancer Prev. 15: 49-54.
20. Davaran S, Rezaei A, Alimohammadi S, Khandaghi AA, Nejati-Koshki K, Nasrabadi HT, Akbarzadeh A. 2014b. Synthesis and physicochemical characterization of biodegradable star-shaped poly lactide-co-glycolide-β-cyclodextrin copolymer nanoparticles containing albumin. Adv Nanoparticles. 3: 14-22.
21. Di Macro A, Arcamone F, Zunino F. 1975. Daunomycin (daunorubicin) and Adriamycin and Structural Analogues, Biological Activity and Mechanism of Action Antimicrobial and Antitumor Agents. Berlin: Springer Verlag, pp. 101-128.
22. Eatemadi A, Daraee H, Karimkhanloo H, Kouhi M, Zarghami N, Akbarzadeh A, et al. 2014a. Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett (in press).
23. Eatemadi A, Daraee H, Zarghami N, Melat Yar H, Akbarzadeh A, Hanifehpour Y. 2014b. Nanofiber: synthesis and biomedical applications. Artif Cells Nanomed Biotechnol. 1-11.
24. Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat S, Akbarzadeh A, Rahmati M, et al. 2013. Inhibition of hTERT Gene Expression by Silibinin-Loaded PLGA-PEG-Fe3O4 in T47D Breast Cancer Cell Line. Bioimpacts. 3: 67-74.
25. Faraasen S, Voros J, Csucs G, Textor M, Merkle HP, Walter E. 2003. Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate. Pharm Res. 20: 237-246.
26. Fekri Aval S, Akbarzadeh A, Rahmati-Yamchi M, Barkhordari A, Mohamadzadeh N, Nejati-Koshki K, et al. 2014. Gene silencing effect of SiRNA-magnetic copolymers on hTERT gene expression in lung cancer cell line. Artif Cells Nanomed Biotechnol 43(7): 1-6.
27. Gandomkar Ghalhar M, Akbarzadeh A, Rahmati M, Mellatyar H, Dariushnejad H, Zarghami N. 2014. Comparison of inhibitory effect of 17-AAG nanoparticles and free 17-AAG in HSP90 gene expression in breast cancer. APJCP. (in press).
28. Gao K, Sun J, Liu K, Liu X, He Z. 2008. Preparation and characterization of a submicron lipid emulsion of docetaxel: Submicron lipid emulsion of docetaxel. Drug Dev Ind Pharm. 34: 1227-1237.
29. Garg T, Goyal AK. 2014. Liposomes: targeted and controlled delivery system. Drug Deliv Lett. 4: 62-71.
30. Ghasemali S, Nejati-Koshki K, Akbarzadeh A, Tafsiri E, Zarghami N, Rahmati-Yamchi M, et al. 2013. Study of inhibitory effect of β-cyclodextrin-helenalin complex on HTERT gene expression in T47D breast cancer cell line by real time quantitative PCR (q-PCR). Asian Pac J Cancer Prev. 14: 6949-6953.
31. Gref R, Minamitake Y, Perracchia MT, Trubetskoy V, Torchilin V, Langer R. 1994. Biodegradable long-circulating poly-meric nanospheres. Science. 263: 1600-1603.
32. Hassani SM, Bagheri S. 2012. Computational procedure for determining physicochemical properties of doxorubicin-PLGA nanoparticles and daunorubicin-PLGA nanoparticles. Int J PharmTech Res. 4: 1242-1246.
33. Huh KM, Cho YW, Park K. 2003. PLGA-PEG block copolymers for drug formulations. Drug Deliv Technol. 3: 44-49.
34. Immordino ML, Brusa P, Arpicco S, Stella B, Dosio F, Cattel L. 2003. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J Control Release. 91: 417-429.
35. Jeong JH, Lim DW, Han DK, Park TG. 2000. Synthesis, characterization and protein adsorption behaviors of PLGA/PEG di-block co-polymer blend films. Colloids Surf B Biointerfaces. 18: 371-379.
36. Karnoosh-Yamchi J, Mobasseri M, Akbarzadeh A, Davaran S, Ostad-Rahimi AR, Hamishehkar H, et al. 2014. Preparation of pH sensitive insulin-loaded Nano hydrogels and evaluation of insulin releasing in different pH conditions. Mol Biol Rep. 14: 3553-3560.
37. Kouhi M, Vahedi A, Akbarzadeh A, Hanifehpour Y, Joo SW. 2014. Investigation of quadratic electro-optic effects and electro absorption process in GaN/AlGaN spherical quantum dot. Nanoscale Res Lett. 9: 131-136.
38. Lee SW, Yun MH, Jeong SW, In CH, Kim JY, Seo MH, et al. 2011. Development of docetaxel-Encapsulated intravenous formulation, Nanoxel-PM™ using polymer-based delivery system. J Control Release. 155: 262-271.
39. Lu AH, Salabas EL, Schüth F. 2007. Magnetic nanoparticles: synthesis, protection functionalization, and application. Angew Chem Int Ed Engl. 46: 1222-1244.
40. Ma Y, Zheng Y, Zeng X, Jiang L, Chen H, Liu R, et al. 2011. Novel docetaxel-encapsulated nanoparticles based on PCL-Tween 80 copolymer for cancer treatment. Int J Nanomed. 6: 2679-2688.
41. Mainardes RM, Evangelista RC. 2005. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 290: 137-144.
42. Manchanda R, Fernandez-Fernandez A, Nagesetti A, McGoron AJ. 2010. Preparation and characterization of a polymeric (PLGA) nano-particulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents. Colloids Surf B Biointerfaces. 75: 260-267.
43. Mollazade M, Nejati-Koshki K, Akbarzadeh A, Hanifehpour Y, Zarghami N, Joo SW. 2013. PAMAM dendrimers arugment inhibitory effect of curcumin on cancer cell proliferation: possible inhibition of telomerase. Asian Pac J Cancer Prev. 14: 6925-6928.
44. Nejati-Koshki K, Akbarzadeh A, Pourhasan-Moghadam M, Joo SW. 2013. Inhibition of leptin and leptin receptor gene expression by silibinin-curcumin combination. Asian Pac J Cancer Prev. 14: 6595-6599.
45. Nejati-Koshki K, Akbarzadeh A, Pourhassan-Moghaddam M, Joo SW, Hanifepour Y. 2014a. Curcumin inhibit leptin gene expression and secretion in breast cancer cells by estrogen receptors. Cancer Cell Int. (in press).
46. Nejati-Koshki K, Mesgari M, Ebrahimi E, Abhari A, Fekri Aval S, Khandaghi AA, Akbarzadeh A. 2014b. Synthesis and In-vitro study of Cisplatin-loaded Fe3O4 Nanoparticles Modified with PLGA-PEG6000 Copolymers in Treatment of Lung Cancer. J Microencapsul (in press).
47. Nidhin M, Indumathy R, Sreeram K, Nair B. 2008. Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide emplates. Bull Mat Sci. 31: 93-96.
48. O'Connell F. 2010. Guidelines for Clinical Management of Lung Cancer/FOREWORD.
49. Peracchia MT, Vauthier C, Passirani C, Couvreur P, Labarre D. 1997. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly- (isobutyl 2-cyanoacrylate) nanoparticles. Life Sci. 61: 749-761.
50. Pourhassan-Moghaddam M, Rahmati-Yamchi M, Akbarzadeh A, Daraee H, Nejati-Koshki K, Hanifehpour Y, Joo SW. 2013. Protein detection through different platforms of immuno-loop-mediated isothermal amplification. Nanoscale Res Lett. 8: 485.
51. Pourhassan-Moghaddam M, Zarghami N, Mohsenifar A, Rahmati-Yamchi M, Gholizadeh D, Akbarzadeh A, et al. 2014. Watercress-based gold nanoparticles: biosynthesis, mechanism of formation and study of their biocompatibility in vitro. IET Digit Library. 4: 5.
52. Quattrin T. 2004. Inhaled insulin: recent advances in the therapy of Type 1 and 2 diabetes Expert Opin. Pharmacother. 5: 2597-2604.
53. Quellec P, Gref R, Perrin L, Dellacherie E, Sommer F, Verbavatz JM, Alonso MJ. 1998. Protein encapsulation within evaporapolyethylene glycol-coated nanospheres. I. Physicochemical characterization. J Biomed Mater Res. 42: 45-54.
54. Rezaei-Sadabady R, Zarghami N, Barzegar A, Eidi A, Akbarzadeh A, Rezaei-Tavirani M. 2013. Studies of the relationship between structure and antioxidant activity in interesting systems, including tyrosol, hydroxytyrosol derivatives indicated by quantum chemical calculations. Soft. 2: 13-18.
55. Sadat Tabatabaei Mirakabad F, Akbarzadeh A, Zarghami N, Zeighamian V, Rahimzadeh A, Alimohammadi S. 2014. PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev. 15: 517-535.
56. Srinophakun T, Boonmee J. 2011. Preliminary study of conformation and drug release mechanism of doxorubicin conjugated glycol chitosan via cis-Aconityl linkage by molecular modeling. Int J Mol Sci. 12: 1672-1683.
57. Tamber H, Johansen P, Merkle HP, Gander B. 2005. Formulationaspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev. 57: 357.
58. Tobío M, Gref R, Sánchez A, Langer R, Alonso MJ. 1998. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res. 15: 270-275.
59. Valizadeh A, Mikaeili H, Samiei M, Farkhani SM, Zarghami N, Kouhi M, et al. 2012. Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett. 7: 480.
60. Verger ML, Fluckiger L, Kim Y, Hoffman M, Maincent P 1998. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm. 46: 137-143.
61. Yadav A, Mishra P, Mishra A, Mishra P, Jain S, Agrawal G. 2007. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine Nanotech Biol Med. 3: 246-257.
62. Yang J, Park SB, Yoon H-G, Hun YM, Haam S. 2006. Preparation of poly ϵ-caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int J Pharm. 324: 185-190.
63. Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, et al. 2004. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 109: 3122-3131.
64. Zhao M, Su M, Lin X, Luo Y, He H, Cai C, Tang X. 2010. Evaluation of docetaxel-Encapsulated intravenous lipid emulsion: Pharmacokinetics, tissue distribution, antitumor activity, safety and toxicity. Pharm Res. 27, 1687-1702.
65. Zohre S, Akbarzadeh A, Kazem NK, Nosratollah Z, Mohammad R, Aliakbar M, et al. 2014. Enhanced expression of klf4 and apoptosis in ovarian and lung cancer by histone deacetylase inhibitor: Trichostatin A. APJCP. 9p.